Publications by authors named "Victoria Copeland"

Claim this Profile
A
Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin Molecules.
Nichole A Reynolds, Yan Q Chen, Richard E Higgs, Boris Calderon, Jeff W Cramer, Victoria Copeland

AAPS J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope mapping using immunopeptidomics reveals novel immunodominant CD8 T cell epitopes of the AAV9 capsid.
Akhila Balasubramanian, Marek Prachar, Birgit Klaproth, Victoria Copeland, Sune Justesen

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure.
Petra Verdino, Stacey L Lee, Fariba N Cooper, Steven R Cottle, Patrick F Grealish, Victoria Copeland

Br J Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"What I Would Do to Take Away Your Pain": A Photovoice Project Conducted by Mothers of Children With Medical Complexity.
Melanie Sonsteng-Person, Javier García-Pérez, Victoria Copeland, Laura Liévano-Karim, Darlene Abrams

Qual Health Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Immune Responses to Oxidation, Deamidation, And Isomerization in Therapeutic Antibodies using Preclinical Immunogenicity Risk Assessment Assays.
Rachel Zeunik, Aya Felicia Ryuzoji, Amber Peariso, Xiaoli Wang, Megan Lannan, Victoria Copeland

J Pharm Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors.
Matthew D Hellmann, Nicoletta Bivi, Boris Calderon, Toshio Shimizu, Brant Delafontaine, Victoria Copeland

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of a GAL4-like transcription factor improves cell fitness and product yield in glycoengineered Pichia pastoris strains.
Bo Jiang, Rebecca Argyros, John Bukowski, Stephanie Nelson, Nathan Sharkey, Victoria Copeland

Appl Environ Microbiol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.
Sita Awasthi, John W Balliet, Jessica A Flynn, John M Lubinski, Carolyn E Shaw, Victoria Copeland

J Virol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris.
Juergen H Nett, Sujatha Gomathinayagam, Stephen R Hamilton, Bing Gong, Robert C Davidson, Victoria Copeland

J Biotechnol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart.
Nita Sachan, Asim Dey, David Rotter, D Bennett Grinsfelder, Pavan K Battiprolu, Victoria Copeland

Circ Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.
Misook Oh, Igor I Rybkin, Victoria Copeland, Michael P Czubryt, John M Shelton

Mol Cell Biol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis